YAP1 and colorectal carcinoma: MiR-375-3p is down-regulated in CRC and analysis of clinical data showed a statistically significant reduction in miR-375-3p levels in stages III–IV compared to stages I–II (Mao et al. 2016), which is inverse to higher YAP1 levels in stages III–IV than in stages I–II (Sun et al. 2019b).